MoneyWorks4Me

A minor change in the total revenue was seen in the June 2022 quarter. The total revenue for the quarter stood at Rs. 1094.95 millions against Rs. 1047.78 millions during year ago period.The Net Profit of the company slipped to Rs. 30.05 millions from Rs. 44.17 millions, a decline of -31.97% on QoQ basis.A decline of 103.84 millions was observed in the OP in the quarter ended June 2022 from 108.72 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 1094.95 1047.78 4.50 1094.95 1047.78 4.50 4510.68 3846.98 17.25
Other Income 0.07 5.22 -98.66 0.07 5.22 -98.66 0.89 0.00 0.00
PBIDT 103.84 108.72 -4.49 103.84 108.72 -4.49 491.45 580.20 -15.30
Interest 35.45 29.62 19.68 35.45 29.62 19.68 111.62 93.26 19.69
PBDT 68.39 79.10 -13.54 68.39 79.10 -13.54 379.83 486.94 -22.00
Depreciation 26.00 23.90 8.79 26.00 23.90 8.79 102.49 91.75 11.71
PBT 42.39 55.20 -23.21 42.39 55.20 -23.21 277.34 395.19 -29.82
TAX 12.34 11.03 11.88 12.34 11.03 11.88 80.76 115.48 -30.07
Deferred Tax -0.96 -4.22 -77.25 -0.96 -4.22 -77.25 -7.32 22.80 -132.11
PAT 30.05 44.17 -31.97 30.05 44.17 -31.97 196.58 279.71 -29.72
Equity 158.28 158.28 0.00 158.28 158.28 0.00 158.28 158.28 0.00
PBIDTM(%) 9.48 10.38 -8.60 9.48 10.38 -8.60 10.90 15.08 -27.76
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..